Streetbeat News

Regulatory

CGEM

Cullinan Oncology announced FDA clearance for its Investigational New Drug application for CLN-619, a novel MICA/B antibody aimed at treating relapsed/refractory multiple myeloma. This marks a significant step forward in the development of new treatments for this challenging form of cancer.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:04 pm

BSX

Boston Scientific announced it has received FDA approval for its Agent drug-coated balloon, designed to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. This approval marks a significant milestone for the company in expanding its cardiovascular treatment portfolio.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 11:57 am

ADM

Archer-Daniels-Midland (ADM) announced it will not be able to file its annual report for the fiscal year ended December 31, 2023, within the prescribed time period. The company expects to file the report by March 15.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 11:50 am

FSR

NTAP

QQQ

SPY

US stocks are set for a modestly lower opening after recent gains, with attention on Fed speeches and economic data. The S&P 500 and Nasdaq hit new highs, while small-caps also saw gains. Premarket trading saw SPY and QQQ ETFs dip slightly. Notable stock movements include NetApp's surge and Fisker's decline post-earnings. Upcoming economic data includes manufacturing PMIs and consumer sentiment. Bond yields dipped, and crude oil futures rose.

Portfolio Pulse from Shanthi Rexaline

March 01, 2024 | 11:31 am

VGK

The preliminary Eurozone Consumer Price Index (CPI) year-over-year has been reported at 2.6%, slightly above the estimated 2.5% and below the prior 2.8%.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 10:09 am

VGK

The Eurozone Consumer Price Index (CPI) for the month showed a preliminary increase of 0.6%, compared to a decrease of -0.4% in the previous month. This indicates a rise in inflation within the Eurozone, which could have implications for market sentiment and monetary policy.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 10:09 am

VGK

The Eurozone Core Consumer Price Index (CPI) for the year-over-year preliminary report showed an increase to 3.1%, compared to the estimated 2.9% and the previous 3.3%.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 10:08 am

VGK

The Eurozone Manufacturing Purchasing Managers Index (PMI) for February was reported at 46.5, slightly above the estimated 46.1 but below the previous month's figure of 46.6.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 9:02 am

BA

Emirates President Tim Clark has warned Boeing (NYSE:BA) to make significant changes following a safety incident where a panel on a MAX 9 jet blew out during a flight, leading to increased regulatory scrutiny. Clark emphasized the need for a change in governance to prevent further issues, highlighting Boeing's recent $51 million penalty for unauthorized exports and ongoing manufacturing challenges.

Portfolio Pulse from Benzinga Neuro

March 01, 2024 | 8:53 am

HUMA

Humacyte has announced a public offering of 13.4 million shares of common stock priced at $3 per share, totaling $40.2 million. The proceeds will be used to advance its regenerative medicine pipeline, support FDA review of its Biologics License Application for bioengineered human acellular vessels for urgent arterial repair, establish initial commercial infrastructure, and for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:08 am